Cargando…

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma

Epidemiological investigations have shown that patients with Parkinson’s disease (PD) have a lower probability of developing lung cancer. Subsequent research revealed that PD and lung cancer share specific genetic alterations. Therefore, the utilisation of PD biomarkers and therapeutic targets may i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanqi, Lu, Xiao, Zhang, Jiao, Liu, Quanxing, Zhou, Dong, Deng, Xufeng, Qiu, Yuan, Chen, Qian, Li, Manyuan, Yang, Guixue, Zheng, Hong, Dai, Jigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488091/ https://www.ncbi.nlm.nih.gov/pubmed/34616772 http://dx.doi.org/10.3389/fmolb.2021.735263

Ejemplares similares

A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification
por: Jiang, Chao, et al.
Publicado: (2022)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
por: Meng, Yiming, et al.
Publicado: (2022)

Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction
por: Zhou, Chengmao, et al.
Publicado: (2020)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression
por: Tang, Lin, et al.
Publicado: (2022)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

Construction of PEI‐EGFR‐PD‐L1‐siRNA dual functional nano‐vaccine and therapeutic efficacy evaluation for lung cancer
por: Yang, Guixue, et al.
Publicado: (2022)

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
por: Fan, Dengxia, et al.
Publicado: (2023)

Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: a comprehensive integrated analysis
por: Dai, Dongjun, et al.
Publicado: (2023)

Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer
por: Gan, Junqing, et al.
Publicado: (2020)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Comprehensive analyses of one-carbon metabolism related genes and their association with prognosis, tumor microenvironment, chemotherapy resistance and immunotherapy in lung adenocarcinoma
por: Zhou, Ning, et al.
Publicado: (2022)

Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer
por: Gan, Junqing, et al.
Publicado: (2021)

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
por: Nai, Aitao, et al.
Publicado: (2022)

Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma
por: Dai, Zili, et al.
Publicado: (2021)

Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

High CTC-TRPC5 Expression Significantly Associated With Poor Prognosis in Radical Resected Colorectal Cancer Patients
por: Cai, Dongyan, et al.
Publicado: (2021)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis
por: Deng, Huan, et al.
Publicado: (2021)

Comprehensive Analysis Revealed the Potential Implications of m6A Regulators in Lung Adenocarcinoma
por: Xie, Lingling, et al.
Publicado: (2022)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Immune Cell Infiltration and Relevant Gene Signatures in the Tumor Microenvironment that Significantly Associates With the Prognosis of Patients With Breast Cancer
por: Xu, Qiang, et al.
Publicado: (2022)

Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma
por: Lin, Guofu, et al.
Publicado: (2021)

Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
por: Li, Nanhong, et al.
Publicado: (2021)

Function and Clinical Significance of Circular RNAs in Thyroid Cancer
por: Yao, Xuelin, et al.
Publicado: (2022)

Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach
por: Wang, Junhao, et al.
Publicado: (2021)

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China
por: Xiaohong, Xie, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Role of Caveolae family-related proteins in the development of breast cancer
por: Han, Qinyu, et al.
Publicado: (2023)

Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies
por: Sun, Aijun, et al.
Publicado: (2023)

Identification of a novel CNV at the APC gene in a Chinese family with familial adenomatous polyposis
por: Li, Juyi, et al.
Publicado: (2023)

Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis
por: Xu, Kailun, et al.
Publicado: (2023)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021)

Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
por: Ye, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s4n4e960qjs1kmtd2c51nh450t